No profile data available.
Biora Therapeutics, Inc. (BIOR) is a healthcare company in the additional medication administration equipment industry, based in San Diego, United States, with about 58 full-time employees.
It reported revenue of $4,000 for fiscal year 2023, down 98.7% from fiscal year 2022, and net income of -$124.12 million. In Q3 2024 (the quarter ended September 30, 2024) revenue was $32,000. Its largest business segment, Commercial Third Party Payors, brought in 69% of segment revenue in fiscal year 2021. Its market capitalization was $994,994 as of January 23, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2023; market data as of January 23, 2026.
, a clinical-stage biotechnology company, engages in developing oral biotherapeutics in the United States.
Biora Therapeutics reported $4,000 in revenue for fiscal year 2023, down 98.7% from $305,000 in fiscal year 2022. In Q3 2024 revenue was $32,000.
Commercial Third Party Payors, with $42.10 million or 69% of segment revenue in fiscal year 2021. Next: Government Health Benefit Programs (23%) and Patient Laboratory Distribution Partners (7%).
$994,994 as of January 23, 2026.
Listed companies of a similar size in the same industry (additional medication administration equipment) include Stevanato Group S.p.A. (STVN), Embecta Corp. (EMBC), Retractable Technologies, Inc. (RVP), Yubo International Biotech Limited (YBGJ).